Inventor
HYUNG-JUNG PYUN
Inventor
US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes28%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C12NMicroorganisms or enzymes3%
C07BGeneral methods of organic chemistry2%
C07CAcyclic or carbocyclic compounds2%
C07HSugars2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
12,521,388Substituted dipyrido[1,2-a:1',2'-d]pyrazines for treating viral infections202612,448,400KRAS G12D modulating compounds202512,421,235Bridged tricyclic carbamoylpyridone compounds and uses thereof202512,377,100Toll like receptor modulator compounds202512,240,862Inhibitors of peptidylarginine deiminases202512,227,520Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use202512,168,002Heterocyclic carboxylate compounds as glycolate oxidase inhibitors202412,161,625Substituted pyrrolizine compounds and uses thereof202411,976,083Inhibitors of peptidylarginine deiminases202411,883,397Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections202411,878,965Inhibitors of peptidylarginine deiminases202411,806,335Heterocyclic carboxylate compounds as glycolate oxidase inhibitors202311,548,901Substituted 1,4-methanopyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines for treating viral infections202311,548,902Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use202311,420,974Substituted pyrrolizine compounds and uses thereof202211,253,524Metabolites of bictegravir202211,213,523Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GILEAD SCIENCES INC (15)· patent assignee history
2022–2026Based in US· patent location history
2023–2024Patents assigned to LILAC THERAPEUTICS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 15 | 2022–2026 |
| LILAC THERAPEUTICS INC | 2 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 17 | 2022–2026 |